Haploidentical natural killer cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Haploidentical natural killer cells, covering 2013-08-28 to 2013-08-28. Get the full timeline:
Most recent: Clinical Trial Update: Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL) [Phase 2]